within Pharmacolibrary.Drugs.V_Various.V03A_AllOtherTherapeuticProducts.V03AC01_Deferoxamine;

model Deferoxamine
  extends Pharmacolibrary.Drugs.ATC.V.V03AC01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>V03AC01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Deferoxamine is a chelating agent used to bind excess iron in the body and is indicated for the treatment of acute iron poisoning and chronic iron overload due to transfusion-dependent anemias such as thalassemia. It is an approved drug and remains in current use, particularly in cases where oral iron chelators are contraindicated or ineffective.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported in adult healthy volunteers and patients with iron overload receiving intramuscular or intravenous administration.</p><h4>References</h4><ol><li><p>Porter, JB (2001). Deferoxamine pharmacokinetics. <i>Seminars in hematology</i> 38(1 Suppl 1) 63–68. DOI:<a href=&quot;https://doi.org/10.1016/s0037-1963(01)90061-7&quot;>10.1016/s0037-1963(01)90061-7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11206963/&quot;>https://pubmed.ncbi.nlm.nih.gov/11206963</a></p></li><li><p>Jones, G, et al., &amp; Kim, J (2022). Pharmacokinetics and tissue distribution of deferoxamine-based nanochelator in rats. <i>Nanomedicine (London, England)</i> 17(22) 1649–1662. DOI:<a href=&quot;https://doi.org/10.2217/nnm-2022-0159&quot;>10.2217/nnm-2022-0159</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36547231/&quot;>https://pubmed.ncbi.nlm.nih.gov/36547231</a></p></li><li><p>Banner, W, &amp; Tong, TG (1986). Iron poisoning. <i>Pediatric clinics of North America</i> 33(2) 393–409. DOI:<a href=&quot;https://doi.org/10.1016/s0031-3955(16)35010-6&quot;>10.1016/s0031-3955(16)35010-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2870463/&quot;>https://pubmed.ncbi.nlm.nih.gov/2870463</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Deferoxamine;
